sj-docx-1-aop-10.1177_10600280211069182 ��� Supplemental material for Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 Infection
- Resource Type
- Source
- Subject
FOS: Clinical medicine 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified respiratory tract diseases - Language
- ISSN
- 1060-0280